≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Postprocedural endocrine and metabolic disorders, not elsewhere classified

MESH PheWeb

E4_ENDOMETPOSTOP

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 E89
Hospital discharge: ICD-9 2440|2513|2562|2572|24409
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 E89
Cause of death: ICD-9 2440|2513|2562|2572|24409
Cause of death: ICD-8 $!$
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 E89.4, E89.5

197583

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

3076

diagram downward connector

Check minimum number of events None

3076

diagram downward connector

Include endpoints None

3076

diagram downward connector
E4_ENDOMETPOSTOP

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E70-E90
Name in latin Perturbationes endocrinae et metabolicae post interventiones non alibi classificatae

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 3076 2457 619
Unadjusted prevalence (%) 0.86 1.24 0.39
Mean age at first event (years) 51.93 51.36 54.20

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 3.24 [1.72, 6.11] 2.8e-4 178
15 years 0.01 1.39 [0.69, 2.84] 3.6e-1 69
5 years 0.00 3.58 [2.11, 6.09] 2.4e-6 60
1 year 0.00 6.67 [3.55, 12.52] 3.7e-9 24

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_ENDOMETPOSTOP – Postprocedural endocrine and metabolic disorders, not elsewhere classified
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Postprocedural endocrine and metabolic disorders, not elsewhere classified
after Postprocedural endocrine and metabolic disorders, not elsewhere classified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Postprocedural endocrine and metabolic disorders, not elsewhere classified

↥